EGFPhi responding cells that segregate into the CD24highCD49low group are also skewed rightwards and express K14, a profile recently ascribed to a CD61+ bipotent progenitor population shown to have cancer stem cell properties [22], [28]. Here, ITGB3 is linked to cancer.